Victoria Chapman, APRN
Gerontology · Minden, LANPI 1073355251
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.3% of the total across 176 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations.
Across 176 payments — averaging $20.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$580
- Incyte Corporation$380
- AstraZeneca$269
- Bayer$245
- Novartis$242
- Takeda Pharmaceuticals U.S.A., Inc.$169
- plus $2K from 29 others
What the payments were for
- Food & beverage$3,40092%
- Education$2838%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 24 | $580 |
| Incyte Corporation | 13 | $380 |
| AstraZeneca(2 entities) | 14 | $269 |
| Bayer | 15 | $245 |
| Novartis | 13 | $242 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $169 |
| Genentech USA, Inc. | 8 | $150 |
| Regeneron Healthcare Solutions, Inc. | 6 | $122 |
| E.r. Squibb & Sons, L.L.C. | 6 | $107 |
| Merck | 5 | $106 |
| Eisai Inc. | 5 | $103 |
| Stemline Therapeutics Inc. | 5 | $89 |
| EMD Serono, Inc. | 4 | $83 |
| GSK | 4 | $82 |
| Pharmacosmos Therapeutics Inc. | 4 | $80 |
| Pharmaessentia USA Corporation | 4 | $78 |
| Bristol Myers Squibb | 4 | $77 |
| Daiichi Sankyo Inc. | 3 | $76 |
| Beigene USA, Inc. | 3 | $70 |
| Astellas Pharma US Inc | 3 | $69 |
| AVEO Pharmaceuticals, Inc. | 3 | $68 |
| Adaptive Biotechnologies Corporation | 3 | $62 |
| Genmab U.S., Inc. | 3 | $60 |
| Tempus AI, Inc | 2 | $49 |
| Pfizer | 3 | $49 |
| Blueprint Medicines Corporation | 1 | $37 |
| Sanofi | 2 | $35 |
| Azurity Pharmaceuticals, Inc. | 1 | $23 |
| Geron Corporation | 1 | $20 |
| Verity Pharmaceuticals Inc. | 1 | $19 |
| Exelixis Inc. | 1 | $19 |
| Deciphera Pharmaceuticals Inc. | 1 | $17 |
| Karyopharm Therapeutics Inc. | 1 | $17 |
| Tolmar, Inc. | 1 | $16 |
| Pharmaand GmbH | 1 | $16 |
How this compares
$3,683 in reported general payments places this provider in the 85th percentile of 64 gerontology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other gerontology in Minden
- Christie McDearmontMinden$1K
- Jodie HarrisonSlidell$12K
- Whitney StevensSlidell$10K
- Rebekah HendryBossier City$6K
- Jessica GaubertBaton Rouge$6K
- Kathy BernsteinNew Orleans$6K
- Katrina GipsonMonroe$6K
- Jennifer HarveySlidell$5K
- Maureen PoeSulphur$5K
- Cynthia TurnerMonroe$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.